Experts focus discussion on FDA's role in comparative effectiveness

02/18/2010 | Medical Devices Today

The FDA's role in comparative-effectiveness research was the focus during a meeting called by a task force of the agency's device center. Diana Zuckerman, a patient advocate, suggested the FDA use comparative studies conducted by groups such as the Agency for Healthcare Research and Quality in assessing the efficacy of new and older devices. Timothy Wright, a principal scientist at a New York hospital, said he believes the agency's role is not comparative effectiveness, but public health.

View Full Article in:

Medical Devices Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX